Could a simple surgical rinse cut infection risk in pilonidal disease?
NCT ID NCT07321704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two rinses used during surgery for pilonidal disease, a chronic skin condition near the tailbone. One rinse is Irrisept, an antiseptic that kills bacteria, and the other is normal saline, the standard rinse. The goal is to see if Irrisept reduces infections and wound complications after flap closure surgery. About 60 adults having this surgery will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Irrisept (0.05% chlorhexidine gluconate antiseptic solution)
- What this could lead to
- If it works, this could point toward a simple way to lower infection and wound problems after pilonidal surgery, helping people heal faster.
- What could go wrong
- This is a small, early-stage trial with only 60 people, so results may not apply to everyone. The antiseptic rinse might not reduce complications more than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PILONIDAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Surgery Group LA
RECRUITINGLos Angeles, California, 90048, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.